Latest / PETRI DISH PERSPECTIVES
Episode 40: Eisai
Send us Fan Mail
What does it take to spend decades chasing one of medicine’s hardest problems while the rest of the industry walks away?
In this episode, we explore the remarkable story of Eisai, the Japanese pharmaceutical company that built its global identity around Alzheimer’s disease. From its founding during World War II and early commitment to ethical medicine, to the blockbuster success of Aricept, and finally the long, controversial road to Leqembi, Eisai’s journey is one of persistence, philosophy, and scientific conviction.
We break down how Eisai partnered with Biogen, why…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.